|
Iberdomide Hydrochloride Clinical Trials
1 actively recruiting trial across 1 location
Also known as: CC-220 Hydrochloride
Atlanta, Georgia1 trial
Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma
Emory University Hospital/Winship Cancer Institute
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.